Among other things, the order requires the Food and Drug Administration to increase its reporting of possible shortages of certain prescription drugs, while also speeding up regulatory reviews of new drug manufacturing sites, drug suppliers and manufacturing changes.
Obama administration officials have also sent a letter to drug manufacturers "reminding them of their responsibility to report the discontinuation of certain drugs to the FDA," the statement noted.
Drug manufacturers are being encouraged to voluntarily disclose possible prescription drug shortages in instances not currently required by law.
The total number of prescription drug shortages almost tripled from 2005 to 2010, the White House noted.
Democrats have been frustrated by GOP opposition to the president's $447 billion jobs plan, as well as a series of other administration-backed measures.